Cargando…
Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria
The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the rec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618154/ https://www.ncbi.nlm.nih.gov/pubmed/34836270 http://dx.doi.org/10.3390/nu13114012 |
_version_ | 1784604679243563008 |
---|---|
author | Scala, Iris Concolino, Daniela Nastasi, Anna Esposito, Giulia Crisci, Daniela Sestito, Simona Ferraro, Stefania Albano, Lucia Ruoppolo, Margherita Parenti, Giancarlo Strisciuglio, Pietro |
author_facet | Scala, Iris Concolino, Daniela Nastasi, Anna Esposito, Giulia Crisci, Daniela Sestito, Simona Ferraro, Stefania Albano, Lucia Ruoppolo, Margherita Parenti, Giancarlo Strisciuglio, Pietro |
author_sort | Scala, Iris |
collection | PubMed |
description | The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments. |
format | Online Article Text |
id | pubmed-8618154 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86181542021-11-27 Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria Scala, Iris Concolino, Daniela Nastasi, Anna Esposito, Giulia Crisci, Daniela Sestito, Simona Ferraro, Stefania Albano, Lucia Ruoppolo, Margherita Parenti, Giancarlo Strisciuglio, Pietro Nutrients Article The mainstay of phenylketonuria treatment is a low protein diet, supplemented with phenylalanine (Phe)-free protein substitutes and micronutrients. Adhering to this diet is challenging, and even patients with good metabolic control who follow the dietary prescriptions in everyday life ignore the recommendations occasionally. The present study explores the ability of slow-release large neutral amino acids (srLNAAs) to prevent Phe increase following a Phe dietary load. Fourteen phenylketonuric patients aged ≥13 years were enrolled in a 6-week protocol. Oral acute Phe loads of 250 and 500 mg were added to the evening meal together with srLNAAs (0.5 gr/kg). Phe and tyrosine were dosed before dinner, 2h-after dinner, and after the overnight fast. After oral Phe loads, mean plasma Phe remained stable and below 600 µmol/L. No Phe peaks were registered. Tyrosine levels significantly increased, and Phe/Tyrosine ratio decreased. No adverse events were registered. In conclusion, a single oral administration of srLNAAs at the dose of 0.5 gr/kg is effective in maintaining stable plasma Phe during acute oral loads with Phe-containing food and may be added to the dietetic scheme in situations in which patients with generally good adherence to diet foresee a higher than prescribed Phe intake due to their commitments. MDPI 2021-11-10 /pmc/articles/PMC8618154/ /pubmed/34836270 http://dx.doi.org/10.3390/nu13114012 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Scala, Iris Concolino, Daniela Nastasi, Anna Esposito, Giulia Crisci, Daniela Sestito, Simona Ferraro, Stefania Albano, Lucia Ruoppolo, Margherita Parenti, Giancarlo Strisciuglio, Pietro Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title | Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title_full | Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title_fullStr | Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title_full_unstemmed | Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title_short | Beneficial Effects of Slow-Release Large Neutral Amino Acids after a Phenylalanine Oral Load in Patients with Phenylketonuria |
title_sort | beneficial effects of slow-release large neutral amino acids after a phenylalanine oral load in patients with phenylketonuria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618154/ https://www.ncbi.nlm.nih.gov/pubmed/34836270 http://dx.doi.org/10.3390/nu13114012 |
work_keys_str_mv | AT scalairis beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT concolinodaniela beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT nastasianna beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT espositogiulia beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT criscidaniela beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT sestitosimona beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT ferrarostefania beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT albanolucia beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT ruoppolomargherita beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT parentigiancarlo beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria AT strisciugliopietro beneficialeffectsofslowreleaselargeneutralaminoacidsafteraphenylalanineoralloadinpatientswithphenylketonuria |